Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01367431 · ClinicalTrials.gov registry record
Xanthohumol and Metabolic Syndrome
A clinical trial, sponsored by Oregon State University.
- Completed
- Registry status
- 48
- Enrollment target
NCT01367431: Completed study, sponsored by Oregon State University.
NCT01367431 is a clinical trial that has completed, run by Oregon State University. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01367431 has completed, sponsored by Oregon State University.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the pharmacokinetics (PK) of xanthohumol (XN). Small amounts of xanthohumol occur naturally in hops, used to make beer, and XN is also found in beer itself. Studies in animals have shown that XN can lower blood sugar and blood lipids such as triglycerides, which can contribute to heart disease. The purpose of this study is to see how much of the XN is absorbed into the blood and how fast it leaves the body when taken by mouth. Once the PK study has been done, the investigators' long-term goal is to learn if xanthohumol can lower risk factors for heart disease and type-2 diabetes in humans.
Primary Outcome
The outcome measures will be the levels of xanthohumol and its metabolites in blood and urine following a single dose of 20 mg, 60mg, or 180 mg of xanthohumol over a course of six days. These levels will be used to determine the pharmacokinetics of xanthohumol in humans.
Interventions
- DIETARY_SUPPLEMENT Xanthohumol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-04 |
What the finished NCT01367431 record still lists
NCT01367431 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 48 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Xanthohumol is the first listed.
NCT01367431 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01367431 about?
NCT01367431 is a clinical study titled "Xanthohumol and Metabolic Syndrome". The purpose of this study is to determine the pharmacokinetics (PK) of xanthohumol (XN). Small amounts of xanthohumol occur naturally in hops, used to make beer, and XN is also found in beer itself. Studies in animals have shown that XN can lower blood sugar and blood lipids such as triglycerides, w...
What is the current status of trial NCT01367431?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2011-08. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01367431?
The interventions under investigation include: Xanthohumol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01367431?
This trial is sponsored by Oregon State University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia